Amphastar Pharmaceuticals, Inc. (AMPH) Financials

AMPH Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.7 billion 975.6 million
March 31, 2026 1.6 billion 874.8 million
Dec. 31, 2025 1.6 billion 840.5 million
Sept. 30, 2025 1.7 billion 889.5 million

AMPH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 42.7 million 7.1 million
March 31, 2026 38.3 million 9.3 million
Dec. 31, 2025 24.6 million 6.2 million
Sept. 30, 2025 47.2 million 6.3 million

AMPH Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 30.3 million
March 31, 2026 6.4 million
Dec. 31, 2025 24.4 million
Sept. 30, 2025 17.4 million

AMPH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 290.1 million 609.6 million 76.3 million
March 31, 2026 294.4 million 609.8 million 65.2 million
Dec. 31, 2025 282.8 million 608.7 million 45.6 million
Sept. 30, 2025 278.6 million 608.6 million 39.4 million

AMPH Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 44.2 million
March 31, 2026 46.5 million
Dec. 31, 2025 47.2 million
Sept. 30, 2025 47.7 million

AMPH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 8.6 million 22.2 million 31.6 million 13.3 million
March 31, 2026 9.5 million 26.7 million 30.0 million 11.9 million
Dec. 31, 2025 8.3 million 23.3 million 26.8 million 10.3 million
Sept. 30, 2025 5.3 million 22.4 million 51.0 million 11.5 million

AMPH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 183.9 million 90.4 million
March 31, 2026 171.2 million 100.8 million
Dec. 31, 2025 183.1 million 97.4 million
Sept. 30, 2025 191.8 million 93.2 million

AMPH Revenue by Segment
Graph available only for paid members. Upgrade to see it.

AMPH

Price: $27.32

52 week price:
16.65
29.52

Payout Ratio Range:
-1783.43%
2384.22%

Earnings Per Share: 1.65 USD

P/E Ratio: 12.11

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 105125

Ebitda: 2.1 million

Market Capitalization: 1.0 billion

Links: